VCYT
VERACYTE, INC.
NASDAQ · Healthcare · Biotechnology · US
$43.80
+1.58%Forward multiples
Based on analyst estimates
- P/E forward
- 23.54x
- P/E 2026E
- 22.89x
- P/E 2027E
- 22.50x
- P/E 2028E
- 21.04x
- P/S forward
- 5.51x
Trailing multiples
Trailing twelve months
- P/E TTM
- 30.42x
- PEG TTM
- 1.04x
- Price / book
- 2.54x
- Price / sales
- 6.27x
- Price / cash flow
- 19.74x
Enterprise value
- Enterprise value
- $3.1B
- EV / sales
- 5.47x
- EV / EBITDA
- 23.70x
- EV / EBIT
- 32.14x
- Market cap
- $3.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026